-+ 0.00%
-+ 0.00%
-+ 0.00%

Genmab, AbbVie Say Lymphoma Drug Failed to Meet Primary Endpoint in Phase 3 Trial

Dow Jones·07/23/2026 20:59:00

Please log in to view news